Ann Arbor Marriott Ypsilanti Eagle Crest

7:00-8:00 Registration and Continental Breakfast

8:00-8:05 Welcome

Ryan Wilcox, MD, PhD
Michigan Medicine, Division of Hematology Oncology; Section Head, Lymphoma and Myeloma

8:05-8:30 My Patient has a T-Cell Lymphoma, Now What?

Ryan Wilcox, MD, PhD

8:30-9:00 DLBCL Management: A State-of-the-Art Review

Yasmin Karimi, MD
Michigan Medicine, Division of Hematology Oncology

9:00-9:30 The Road There and Back Again. The Journey of Immunotherapy in Lymphoma

Tycel Phillips, MD
City of Hope Comprehensive Cancer Center, Los Angeles, CA

9:30-10:00 Frontline Management of Myeloma: A State-of-the-Art Review

Matt Pianko, MD
Michigan Medicine, Division of Hematology Oncology

10:00-10:30 Coffee Break and Networking

10:40-11:10 Advances in the Management of Relapsed/ refractory Myeloma

Erica Campagnaro, MD
Michigan Medicine, Division of Hematology Oncology

11:10-11:40 Advances in CAR T-cell Therapy for Lymphoma

Monalisa Ghosh, MD
Michigan Medicine, Division of Hematology Oncology

12:00-1:00 Buffet Lunch

1:00-2:00 Keynote Address: Myeloproliferative Neoplasms: 2023 update

Ayalew Tefferi, MD
Barbara Woodward Lips Professor of Medicine, Mayo Clinic, Division of Hematology, Rochester, MN

2:00-2:20 Clinical Debates in AML

Dale Bixby, MD, PhD, Michigan Medicine, Division of Hematology Oncology
Bernard Marini, PharmD,  Michigan Medicine, Pharmacy

Anthony Perissinotti, PharmD, Michigan Medicine, Pharmacy

2:40-3:05 CML: Past and Present

Moshe Talpaz, MD
Michigan Medicine, Division of Hematology Oncology

Alexander J. Trotman Professor for Leukemia Research, Associate Division Chief for Hematology

3:05-3:30 Challenging MPN Cases

Kristen Pettit, MD
Michigan Medicine, Division of Hematology Oncology

3:30-3:40 Closing Remarks

Moshe Talpaz, MD

3:40-4:30 Hors d’oeuvres and Networking Reception